Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AU-15506
i
Other names:
AU-15506
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Dr. Reddy’s
Drug class:
CDK12 inhibitor, CDK13 inhibitor
Related drugs:
‹
AU-16770 (1)
CDK12/13 inhibitor (0)
CTX-439 (0)
ISM6466A (0)
KIN004 (0)
OKI-1546 (0)
Undisclosed CDK12 inhibitor (0)
Undisclosed CDK12 inhibitor (0)
AU-16770 (1)
CDK12/13 inhibitor (0)
CTX-439 (0)
ISM6466A (0)
KIN004 (0)
OKI-1546 (0)
Undisclosed CDK12 inhibitor (0)
Undisclosed CDK12 inhibitor (0)
›
Associations
(1)
News
Twitter
Trials
VERI cancer hierarchy
x
x
x
x
Reset Filters
EGFR mutation
Lung Adenocarcinoma
EGFR mutation
Lung Adenocarcinoma
osimertinib + AU-15506
Sensitive: D – Preclinical
osimertinib + AU-15506
Sensitive
:
D
osimertinib + AU-15506
Sensitive: D – Preclinical
osimertinib + AU-15506
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login